|
End-of-day quote
Buenos Aires S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 24,160.00 ARS | -1.23% |
|
+3.65% | +44.93% |
| 05:31pm | Amgen drug combined with immunotherapy extends survival in lung cancer trial | RE |
| 10-23 | Amgen's Growth Drivers, Pipeline Could Support Longer-Term Outlook, Oppenheimer Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.23% | +3.65% | +44.93% | +58.95% | +1,625.71% | 237B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
